PE20080064A1 - N-oxidos de derivados de piridilmetilpiperazina y piridilmetilpiperidina - Google Patents
N-oxidos de derivados de piridilmetilpiperazina y piridilmetilpiperidinaInfo
- Publication number
- PE20080064A1 PE20080064A1 PE2007000537A PE2007000537A PE20080064A1 PE 20080064 A1 PE20080064 A1 PE 20080064A1 PE 2007000537 A PE2007000537 A PE 2007000537A PE 2007000537 A PE2007000537 A PE 2007000537A PE 20080064 A1 PE20080064 A1 PE 20080064A1
- Authority
- PE
- Peru
- Prior art keywords
- alcoxyl
- alkyl
- pyridyl
- pyridylmethylpiperidine
- pyridylmethylpiperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A COMPUESTOS N-OXIDOS DE DERIVADOS DE PIRIDILMETILPIPERAZINA Y PIRIDILMETILPIPERIDINA DE FORMULA (a) DONDE A ES UN HETEROCICLICO DE 5 A 7 MIEMBROS; R1 ES H O F; R2 ES ALQUILO(C1-C4), ALCOXILO(C1-C4) U OXO; p ES DE 0 A 2; Z ES C O N; LA LINEA PUNTEADA ES UN ENLACE SIMPLE O DOBLE; R3 Y R4 SON CADA UNO H O ALQUILO(C1-C4); n ES 1 O 2; R5 ES 2-PIRIDIL, 3-PIRIDIL O 4-PIRIDIL SUSTITUIDO CON Y O (R6)q, DONDE Y ES FENILO, FURANILO O TIENILO OPCIONALMENTE SUSTITUIDOS CON OH, HALOGENO, CF3, ALCOXILO(C1-C4), ENTRE OTROS; R6 ES HALOGENO, OH, ALCOXILO(C1-C4) O ALQUILO(C1-C4); q ES DE 0 A 3. SON COMPUESTOS PREFERIDOS: 1-(2,3-DIHIDRO-1,4-BENZODIOXIN-5-IL)-4-[[5-(4-FLUOROFENIL)-1-OXIDO-3-PIRIDINIL]METIL]-PIPERAZINA, 1-(2,3-DIHIDRO-1,4-BENZODIOXIN-5-IL)-4-[[5-(4-FLUOROFENIL)-3-PIRIDINIL]METIL]-4-OXIDO-PIPERAZINA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE DOPAMINA D2 Y AGONISTAS DEL RECEPTOR DE SEROTONINA 5-HT1A SIENDO UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON, ANSIEDAD, AUTISMO, DEPRESION, ESQUIZOFRENIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06113393 | 2006-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080064A1 true PE20080064A1 (es) | 2008-03-19 |
Family
ID=37198739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000537A PE20080064A1 (es) | 2006-05-02 | 2007-05-02 | N-oxidos de derivados de piridilmetilpiperazina y piridilmetilpiperidina |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP2024363B1 (es) |
JP (1) | JP2009535374A (es) |
CN (1) | CN101432279A (es) |
AR (1) | AR060832A1 (es) |
AU (1) | AU2007247251B2 (es) |
BR (1) | BRPI0710792A2 (es) |
CA (1) | CA2649479A1 (es) |
CL (1) | CL2007001245A1 (es) |
EA (1) | EA200870492A1 (es) |
MX (1) | MX2008013887A (es) |
PE (1) | PE20080064A1 (es) |
SA (1) | SA07280218B1 (es) |
TW (1) | TW200811150A (es) |
UA (1) | UA96756C2 (es) |
WO (1) | WO2007128694A1 (es) |
ZA (1) | ZA200809112B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2146961E (pt) | 2007-04-12 | 2014-04-30 | Ivax Int Gmbh | Derivados de n-óxido e/ou di-n-óxido de estabilizadores / moduladores dos recetores da dopamina exibindo perfis de efeitos secundários cardiovasculares melhorados |
TWI579272B (zh) | 2011-12-08 | 2017-04-21 | 梯瓦製藥國際有限責任公司 | 普多比啶(pridopidine)之氫溴酸鹽 |
KR20150013476A (ko) | 2012-04-04 | 2015-02-05 | 아이백스 인터내셔널 게엠베하 | 조합요법용 약학적 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE81975T1 (de) | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
TW530054B (en) | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
-
2007
- 2007-04-25 WO PCT/EP2007/054048 patent/WO2007128694A1/en active Application Filing
- 2007-04-25 JP JP2009508315A patent/JP2009535374A/ja not_active Withdrawn
- 2007-04-25 CN CNA2007800157788A patent/CN101432279A/zh active Pending
- 2007-04-25 BR BRPI0710792-7A patent/BRPI0710792A2/pt not_active IP Right Cessation
- 2007-04-25 CA CA002649479A patent/CA2649479A1/en not_active Abandoned
- 2007-04-25 EA EA200870492A patent/EA200870492A1/ru unknown
- 2007-04-25 EP EP07728504A patent/EP2024363B1/en active Active
- 2007-04-25 AU AU2007247251A patent/AU2007247251B2/en not_active Ceased
- 2007-04-25 MX MX2008013887A patent/MX2008013887A/es unknown
- 2007-04-25 UA UAA200813798A patent/UA96756C2/ru unknown
- 2007-04-30 CL CL200701245A patent/CL2007001245A1/es unknown
- 2007-05-01 TW TW096115482A patent/TW200811150A/zh unknown
- 2007-05-02 PE PE2007000537A patent/PE20080064A1/es not_active Application Discontinuation
- 2007-05-02 AR ARP070101891A patent/AR060832A1/es not_active Application Discontinuation
- 2007-05-02 SA SA07280218A patent/SA07280218B1/ar unknown
-
2008
- 2008-10-23 ZA ZA200809112A patent/ZA200809112B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MX2008013887A (es) | 2009-01-29 |
CA2649479A1 (en) | 2007-11-15 |
EA200870492A1 (ru) | 2009-04-28 |
BRPI0710792A2 (pt) | 2011-06-21 |
CL2007001245A1 (es) | 2008-05-30 |
EP2024363B1 (en) | 2012-08-01 |
AU2007247251A1 (en) | 2007-11-15 |
SA07280218B1 (ar) | 2010-10-03 |
AR060832A1 (es) | 2008-07-16 |
EP2024363A1 (en) | 2009-02-18 |
ZA200809112B (en) | 2009-07-29 |
TW200811150A (en) | 2008-03-01 |
CN101432279A (zh) | 2009-05-13 |
WO2007128694A1 (en) | 2007-11-15 |
AU2007247251B2 (en) | 2011-11-03 |
JP2009535374A (ja) | 2009-10-01 |
UA96756C2 (en) | 2011-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090741A1 (es) | Derivados de 1,1,1-trifluor-2-hidroxi-3-fenilpropano | |
PE20090717A1 (es) | Derivados de quinolina como inhibidores de la pi3 quinasa | |
PE20110237A1 (es) | Derivados de ciclohexilamida como antagonistas del receptor del factor de liberacion de corticotropina (crf-1) | |
PE20120321A1 (es) | Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa | |
PE20090714A1 (es) | Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido | |
HRP20151435T1 (hr) | Diamino heterociklički karboksamidni spoj | |
PE20090288A1 (es) | Derivados de quinoxalina como inhibidores de la pi3 quinasa | |
PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
PE20141375A1 (es) | Activadores de glucoquinasa | |
NZ589962A (en) | Inhibitors of stearoyl-CoA desaturase and uses thereof | |
PE20081845A1 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
PE20120650A1 (es) | Acetamidas sustituidas por n-(hetero)-arilo y 2-(hetero)-arilo, como moduladores de la senalizacion de wnt | |
PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
PE20091379A1 (es) | Piridinil amidas para el tratamiento de transtornos del snc y metabolicos | |
PE20081404A1 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona y procesos para su preparacion | |
NZ630124A (en) | Estrogen receptor modulators and uses thereof | |
NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
PE20080890A1 (es) | DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES | |
PE20081532A1 (es) | Compuestos novedosos | |
PE20090773A1 (es) | Derivados de morfolina pirimidina | |
PE20100087A1 (es) | Compuestos y composiciones como inhibidores de cinasa | |
PE20090886A1 (es) | Nuevos inhibidores de quinasa | |
PE20071171A1 (es) | Derivados de acido nicotinico como moduladores de receptores de glutamato metabotropicos | |
PE20060079A1 (es) | DERIVADOS DE PIRIDILO COMO ANTAGONISTAS DEL RECEPTOR mGlus5 | |
PE20061377A1 (es) | Compuestos heterociclicos fusionados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |